The final of three Lectureship Award sessions at WCLC 20222 will take place tomorrow, August 9, beginning at 13:15 CEST in Hall C1. The session will also be live-streamed and available on-demand for virtual attendees.
Each year during the world conference, IASLC presents awards to clinicians and researchers who have made significant contributions to the treatment of patients with lung cancer. The awardees are invited to receive their awards and deliver a state-of-the-art lecture at the conference. Following are the awards and lectures that will be presented during Tuesday’s Lectureship Awards session.
- Time: 13:15-14:15 CEST
- Date: Tuesday, August 9
- Location: Hall C1, Live & On-Demand
Fred R. Hirsch Lectureship Award for Translational Research
Lukas Bubendorf, MD, was honored with the Fred R. Hirsh Lectureship Award for Translational Research. During his award lecture, titled “Pathology in Transition,” Dr. Bubendorf will discuss how the field of pathology, in general, and lung pathology, in particular, has dramatically evolved during the past two decades, concluding with a look at anticipated future developments.
“New technological and scientific discoveries have created new opportunities in research and diagnostic routine allowing for comprehensive genomic and transcriptomic analyses to elucidate the machinery behind the H&E (hematoxylin and eosin) morphology that pathologists have relied on in the past,” Dr. Bubendorf said.
The revolution of precision medicine and immunotherapy, he said, has led to a new role and new responsibility for pathologists to help in guiding therapy decisions in patients with lung cancer by providing comprehensive predictive biomarker testing.
“And other new challenges and opportunities lie ahead of us,” Dr. Bubendorf said. “In particular, digital pathology and artificial intelligence will rapidly evolve and spread out in the next few years to assist pathologists in more efficiently dissecting diagnosis, prognostication, and prediction in thoracic cancers, as well as facilitating global interaction. The field of thoracic pathology definitely remains exciting.”
Dr. Bubendorf is a surgical pathologist and head of cytopathology at the Institute for Pathology of the University Hospital Basel in Switzerland. He is a member of numerous national and international scientific societies, the Steering Committee of the European Thoracic Oncology Platform Lungscape project, the IASLC Pathology Committee, and he serves on the editorial boards of several journals.
IASLC Lectureship Award for Nurses and Allied Health Professionals
Research fellow Anne Fraser has worked in the field of lung cancer for more than 15 years as a research nurse and clinical nurse specialist. For the past 10 years, she has worked as an oncology nurse practitioner.
In recognition of her contributions to oncology nursing, Ms. Fraser will present the IASLC Lectureship Award for Nurses and Allied Health Professions.
Ms. Fraser is currently working on a lung cancer screening study with the indigenous Māori population in New Zealand. She’s also exploring surveillance models for people with lung cancer while completing her PhD.
Clifton F. Mountain Lectureship Award for Staging
Clarissa Mathias, MD, winner of the Clifton F. Mountain Lectureship Award for Staging, will present “How Can We Shape (and Stage) the Future of Lung Cancer?” during Tuesday’s session.
In her address, Dr. Mathias will discuss how lung cancer is currently staged and how, with new and emerging treatments and technologies, it will be staged in the future.
“We have a major responsibility to improve our staging abilities and to make it available to the largest number of patients, thereby improving their care,” Dr. Mathias said.
Dr. Mathias is a medical oncologist at NOB/Oncoclinicas in Brazil. She is a member of the ASCO International Quality Steering Group and Lung Cancer committee. She has served on the IASLC Board of Directors and is Past-President of the Brazilian Society of Clinical Oncology.